Literature DB >> 8726343

Anabolic steroid use and associated health risk behaviours.

A B Middleman1, R H DuRant.   

Abstract

Androgenic-anabolic steroid use is a significant problem among young people. The abuse of steroids may cause significant medical problems. Adolescent steroid users have also been found to be more likely than non-users to be engaging in other high risk behaviours including multiple drug use, cigarette and smokeless tobacco use, suicidal behaviours, high risk sexual behaviours, carrying a weapon, and fighting behaviours. It is critical that clinicians and athletic coaches and trainers are aware of these associations in order to more carefully screen and advise adolescents for health risk behaviours.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8726343     DOI: 10.2165/00007256-199621040-00001

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  21 in total

1.  Anabolic steroid users--another potential risk group for HIV infection.

Authors:  P M Nemechek
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

2.  AIDS in a bodybuilder using anabolic steroids.

Authors:  H M Sklarek; R P Mantovani; E Erens; D Heisler; M S Niederman; A M Fein
Journal:  N Engl J Med       Date:  1984-12-27       Impact factor: 91.245

Review 3.  Anabolic steroid use in adolescent athletes.

Authors:  M D Johnson
Journal:  Pediatr Clin North Am       Date:  1990-10       Impact factor: 3.278

4.  Prevalence of anabolic steroid use by male and female adolescents.

Authors:  R Windsor; D Dumitru
Journal:  Med Sci Sports Exerc       Date:  1989-10       Impact factor: 5.411

5.  Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes.

Authors:  H G Pope; D L Katz
Journal:  Arch Gen Psychiatry       Date:  1994-05

6.  Anabolic steroid use by male adolescents.

Authors:  M D Johnson; M S Jay; B Shoup; V I Rickert
Journal:  Pediatrics       Date:  1989-06       Impact factor: 7.124

Review 7.  Affective and psychotic symptoms associated with anabolic steroid use.

Authors:  H G Pope; D L Katz
Journal:  Am J Psychiatry       Date:  1988-04       Impact factor: 18.112

8.  Anabolic steroid use: indications of habituation among adolescents.

Authors:  C E Yesalis; A L Streit; J R Vicary; K E Friedl; D Brannon; W Buckley
Journal:  J Drug Educ       Date:  1989

9.  Estimated prevalence of anabolic steroid use among male high school seniors.

Authors:  W E Buckley; C E Yesalis; K E Friedl; W A Anderson; A L Streit; J E Wright
Journal:  JAMA       Date:  1988-12-16       Impact factor: 56.272

10.  Anabolic steroid use among substance abusers in treatment.

Authors:  G P Clancy; W R Yates
Journal:  J Clin Psychiatry       Date:  1992-03       Impact factor: 4.384

View more
  5 in total

Review 1.  Risk factors associated with anabolic-androgenic steroid use among adolescents.

Authors:  M S Bahrke; C E Yesalis; A N Kopstein; J A Stephens
Journal:  Sports Med       Date:  2000-06       Impact factor: 11.136

2.  Electrospray and atmospheric pressure chemical ionization tandem mass spectrometric behavior of eight anabolic steroid glucuronides.

Authors:  T Kuuranne; M Vahermo; A Leinonen; R Kostianen
Journal:  J Am Soc Mass Spectrom       Date:  2000-08       Impact factor: 3.109

3.  Anabolic-androgenic steroid use among high school football players.

Authors:  V G Stilger; C E Yesalis
Journal:  J Community Health       Date:  1999-04

Review 4.  Understanding Risky Behavior: The Influence of Cognitive, Emotional and Hormonal Factors on Decision-Making under Risk.

Authors:  Petko Kusev; Harry Purser; Renata Heilman; Alex J Cooke; Paul Van Schaik; Victoria Baranova; Rose Martin; Peter Ayton
Journal:  Front Psychol       Date:  2017-02-01

5.  Factors associated with herb and dietary supplement use by young adults in the United States.

Authors:  Paula Gardiner; Kathi J Kemper; Anna Legedza; Russell S Phillips
Journal:  BMC Complement Altern Med       Date:  2007-11-30       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.